155 S. Limerick Road
411 articles with Teleflex Incorporated
Teleflex Announces Fourth Quarter and Full Year 2019 Earnings Conference Call InformationLive Webcast is scheduled at 8:00 a.m. (ET) on Thursday, February 20, 2020
Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2019 will be released before market open on Thursday, February 20, 2020. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, February 20, 2020.
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that it received 510(k) clearance from the U.S. Food and Drug Administration for the WattsonTM Temporary Pacing Guidewire – the first commercially available bipolar temporary pacing guidewire designed specifically for use during transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV).
Teleflex Convenes Urologists in Australia for Summit on Treating Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
Teleflex Incorporated (NYSE: TFX) recently hosted urologists from around the world to review clinical data and share best practices for using the UroLift® System to improve the care of patients with an enlarged prostate, or benign prostatic hyperplasia (BPH).
Teleflex Announces FDA Clearance for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc
Minimally Invasive Procedure Now Available to Hundreds of Thousands More Men with Enlarged Prostate, Providing Safe and Effective Symptom Relief
Liam Kelly, President and CEO, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at the 38th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California
Teleflex to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top
Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top conference at the Goldman Sachs Office in New York, NY, on Thursday, January 9, 2020 at 2:50 p.m. (ET).
Teleflex Ranked a Best Place to Work by MedReps.comFor the third consecutive year, Teleflex earned a top spot as a best place to work by United States sales professionals in the annual MedReps.com Best Places to Work Survey
Teleflex Incorporated announced that it was named the winner of MedReps.com’s 9th Annual Best Places to Work 2020 survey for the Large Category Best Medical Device Companies and came in second in the Overall Category, covering Best Medical Device Companies, Best Pharma Companies and Best Biotech Companies.
Liam Kelly, President and CEO, Teleflex Incorporated, is scheduled to speak at the 31st Annual Piper Jaffray Healthcare Conference at The Lotte New York Palace Hotel, in New York City, on Thursday, December 5, 2019 at 9:00 a.m.
Teleflex to Showcase its Interventional Portfolio Highlighting the MANTA® Vascular Closure Device and the Langston® Dual Lumen Catheters at the PCR London Valves 2019
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, will showcase its Interventional product portfolio including the MANTA® Vascular Closure Device and Langston® Dual Lumen Catheters at the PCR London Valves being held in London, United Kingdom on November, 17th – 19th, 2019.
Liam Kelly, President and CEO, Teleflex Incorporated, is scheduled to speak at the Stephens Nashville 2019 Investment Conference at the Omni Nashville Hotel in Nashville, TN, on Thursday, November 14, 2019 at 9:00 a.m.
Third Quarter Revenues from Continuing Operations of $648.3 million, up 6.3% versus the Prior Year Period; up 8.0% on a Constant Currency Basis
Teleflex Incorporated announced that its Board of Directors declared a quarterly cash dividend of thirty-four cents per share of common stock.
Teleflex Announces Third Quarter 2019 Earnings Conference Call Information Live Webcast is scheduled at 8:00 a.m. (ET) on Thursday, October 31, 2019
Teleflex Incorporated announced that financial results for the third quarter 2019 will be released before market open on Thursday, October 31, 2019.
ACTO and Teleflex Collaboration Leads to Improved Sales Performance and Wins Bronze in the 2019 Brandon Hall Group Human Capital Management Excellence Awards for Learning Technology Implementation
ACTO and Teleflex's Vascular Division won a coveted Brandon Hall Group Bronze award for excellence in the "Best Advance in Learning Technology Implementation" category for their groundbreaking efforts to improve sales performance.
The incidence of urethral stricture disease, in which the urethral opening becomes narrow due to genetic disorders, scars, or infections such as STD, is increasing significantly.
Titan Medical and Teleflex Incorporated Announce Collaboration for Development of Robotic Ligation Technology
Titan Medical Inc. announce a collaboration under which Teleflex’s market-leading polymer ligation technology will be integrated into Titan’s development-stage, single-port robotic surgery system.
Liam Kelly, President and Chief Executive Officer, Teleflex Incorporated, is scheduled to speak at Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Miami Beach, Florida, on Tuesday, March 12, 2019 at 8:00 am.
Teleflex Incorporated announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents per share of common stock.
Fourth Quarter 2018 Revenues of $641.6 million, up 7.8% Versus Prior Year Period; up 9.4% on a Constant Currency Basis
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, has been awarded a group purchasing agreement for SURPASS with Premier.